News – Page 957 – Endpoints News

Top 5 Chinese players: What does Everest's landmark deal with Immunomedics say about the flurry of in-licensing to ...

7 years ago

Incyte pulls away 'damaged goods' baricitinib to focus on internal pipeline

7 years ago

Suffering a series of setbacks, Eli Lilly's oncology group quietly executes 2 of its top mid-stage drugs

7 years ago

As Eli Lilly suffers a sharp setback on revenue projections, the oncology group quietly executes 2 of its top ...

7 years ago

Codiak Biosciences outlines a new focus for its exosome platform in $86M IPO filing

7 years ago

Analyst pens a barbed note to Biogen: Shed caution, dump Alzheimer’s and retool at the top — go bold

7 years ago

Vowing to spark a revolution in small molecule R&D, Vividion equips itself with an extra $82M for the final stretch ...

7 years ago

A biotech fledgling cross-bred in France and Switzerland launches to take on liver problems of global dimensions

7 years ago

EU universities are miserably lax at reporting clinical trial results, analysis suggests

7 years ago

Portola gets EU clearance to market Andexxa under new name; Four biotechs set terms for Nasdaq debut

7 years ago

FDA tags Bayer's prostate cancer drug for priority review as drugmaker gears up against rivals

7 years ago

Roiled by C-suite turmoil and a CRL, Immunomedics salutes CMO Rob Iannone as he makes a quick exit

7 years ago

After promising M&A and buybacks to revive long-term prospects, Biogen refreshes board with three appointments to ...

7 years ago

Eyeing RNAi potential in cancer and fibrosis, trans-Pacific biotech Sirnaomics lines up $47M Series C

7 years ago

Fired for code of conduct violations, Ian Smith still grabbed a multimillion-dollar stock package at Vertex — but ...

7 years ago

As Praluent Q1 sales miss Wall Street expectations, FDA expands drug's label to reflect CV risk reduction

7 years ago

Three biotechs reveal some secrets about themselves as they gun for $271M-plus in IPOs

7 years ago

Len Schleifer and George Yancopoulos once again land in the top ranks of the highest paid execs in biopharma

7 years ago

Peer Review: Don Hayden commits to CEO role at WindMIL; X4 nabs new CMO Lynne Kelley from Histogenics exile

7 years ago

Celgene submits EU marketing pitch for luspatercept; Bausch Health wins FDA approval for topical psoriasis treatment

7 years ago

Keytruda PhIII failure in gastric cancer blights Merck's quest for frontline dominance

7 years ago

Canine club: Elanco Animal Health makes takeover play for partner Aratana in up to $245M deal

7 years ago

‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major ...

7 years ago

Roche delays $4.3B Spark buyout — again — as FTC review drags on

7 years ago

First page Previous page 954 955 956957958 959 960 Next page Last page